| Issue |
Med Sci (Paris)
Volume 42, Number 2, Février 2026
|
|
|---|---|---|
| Page(s) | 137 - 140 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2026009 | |
| Published online | 24 February 2026 | |
Déméthyler l’ADN contre le cancer
Vers de nouvelles stratégies épigénétiques sans dommage à l’ADN
Demethylating DNA against cancer : towards new epigenetic therapeutic strategies without DNA damage
UMR7216, Épigénétique et destin cellulaire, Université Paris Cité, CNRS, Paris, France
a
This email address is being protected from spambots. You need JavaScript enabled to view it.
b
This email address is being protected from spambots. You need JavaScript enabled to view it.
c
This email address is being protected from spambots. You need JavaScript enabled to view it.
Cet article ne possède pas de résumé.
© 2026 médecine/sciences – Inserm
Article publié sous les conditions définies par la licence Creative Commons Attribution License CC-BY (https://creativecommons.org/licenses/by/4.0), qui autorise sans restrictions l’utilisation, la diffusion, et la reproduction sur quelque support que ce soit, sous réserve de citation correcte de la publication originale.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
